Home » ulcers » Recent Articles:

Proton-Pump Inhibitor Plus Clopidogrel Is Less Likely To Cause Bleeding Ulcers

March 16, 2010 Health News No Comments

Heart patients who took a stomach acid-suppressing proton-pump inhibitor along with clopidogrel a drug that prevents blood clots were only half as likely to be hospitalized for upper digestive tract bleeding than those who used clopidogrel alone, according to a new study supported by HHS’ Agency for Healthcare Research and Quality and the National Heart, Lung, and Blood Institute at the National Institutes of Health. The study also suggested that combining the drugs did not increase the risk of serious heart problems…

Go to Source… Continue reading

Cardium Reports On Recent Norwegian Study Revealing That History Of Foot Ulcers Is A Significant Predictor Of Mortality In Diabetic Patients

December 17, 2009 Health News No Comments

Cardium Therapeutics (NYSE Amex: CXM) reported on recent clinical findings published in the December issue of Diabetes Care showing an increase in mortality in diabetic patients with a history of foot ulcer (HFU) compared with diabetic patients without HFU and with non-diabetic patients. The study titled, “A history of foot ulcer increases mortality among persons with diabetes. 10-year follow-up of the Nord-Trondelag Health Study, Norway”, (Diabetes Care. 2009 Dec;32(12): 2193-9…

Go to Source… Continue reading

Diabetic foot ulcer treatment

November 26, 2009 Health News No Comments

Diabetics face many health challenges, and among them is the risk of developing foot ulcers.

“Foot ulcers can be painful and can lead to further infections and even limb amputation if they are not monitored or treated correctly,” said Marcus M. Riedhammer, M.D., Certified Wound Specialist, Geisinger Medical Center. “Diabetes can cause nerve damage, which lessens a diabetic’s ability to feel when an injury develops, and it can adversely affect circulation and the body’s ability to help wounds heal or fight off infection. Because of these issues, diabetics are particularly susceptible to developing foot ulcers.”

[/caption]

Foot… Continue reading

To Heal Diabetic Foot Ulcers, A New Drug Harnesses Stem Cells Inside Us All

November 11, 2009 Health News No Comments

Diabetic foot ulcers are the primary cause of hospital admissions for diabetics. Foot ulcers that heal improperly are at risk for infection, which can lead to amputation. According to the American Diabetes Association, one in four patients with diabetic foot ulcers will eventually require lower-limb amputation.

Go to Source… Continue reading

About Peptic ulcer

November 9, 2009 Peptic Ulcer No Comments

A peptic ulcer, also known as ulcus pepticum, PUD or peptic ulcer disease,  is an ulcer (defined as mucosal erosions equal to or greater than 0.5 cm) of an area of the gastrointestinal tract that is usually acidic and thus extremely painful. As many as 80% of ulcers are associated with Helicobacter pylori, a spiral-shaped bacterium that lives in the acidic environment of the stomach, however only 20% of those cases go to a doctor. Ulcers can also be caused or worsened by drugs such as aspirin and other NSAIDs.
Contrary to general belief, more peptic ulcers arise in the… Continue reading

Factors of importance to the development of pressure ulcers in the care trajectory: perceptions of hospital and community care nurses

November 5, 2009 Peptic Ulcer No Comments

Conclusion. The study both confirmed previous findings and added new knowledge about factors that may affect pressure ulcer in the trajectory of care. The informants’ views of nurses’ responsibilities and their attitudes towards the care of pressure ulcers could, along with their views on the organisation of care, increase the understanding of the occurrence of pressure ulcers. The need for development and clarification of the organisation and responsibility of pressure ulcer care in the care trajectory was stressed.Relevance to clinical practice. The study highlighted attitudes and values among registered nurses, as well as to how to preserve their commitment and… Continue reading

Gastric ulcer, Duodenal ulcer and Esophageal ulcer information

September 28, 2009 Peptic Ulcer No Comments

A peptic ulcer is a hole in the gut lining of the stomach, duodenum, or esophagus. A peptic ulcer of the stomach is called a gastric ulcer; of the duodenum, a duodenal ulcer; and of the esophagus, an esophageal ulcer. An ulcer occurs when the lining of these organs is corroded by the acidic digestive juices which are secreted by the stomach cells. Peptic ulcer disease is common, affecting millions of Americans yearly. The medical cost of treating peptic ulcer and its complications runs in the billions of dollars annually. Recent medical advances have increased our understanding of ulcer formation… Continue reading

Peptic Ulcer? Effective Natural Remedies

September 16, 2009 Peptic Ulcer No Comments

Peptic ulcers, which can affect both the stomach (gastric ulcers) and the first part of the small intestine (duodenal ulcers), blight the lives of millions of people.

Peptic ulcers, which can affect both the stomach (gastric ulcers) and the first part of the small intestine (duodenal ulcers), blight the lives of millions of people. In the UK, 10 to 15 per cent of the population are affected by this condition, with men being more susceptible than women.

Peptic ulcers do not always cause sufferers to experience any pain but, in the majority of cases, they cause a dull… Continue reading

ADS:

Featured Content:

Single Institutional Experience With Nephron-Sparing Surgery For Pathologic Stage T3bNxM0 Renal Cell Carcinoma Confined To The Renal Vein

March 19, 2010

UroToday – Our study of nephron sparing surgery in renal cell carcinoma (RCC) invading the segmental branches of the renal vein is consistent with the trend towards increased utilization of “partial nephrectomy” during surgical management of RCC. This strategy is particularly useful in those with preexisting impairment of renal function and with a modest follow-up we have found good cancer control in these select patients…

Go to Source… Continue reading

Single Institutional Experience With Nephron-Sparing Surgery For Pathologic Stage T3bNxM0 Renal Cell Carcinoma Confined To The Renal Vein

March 19, 2010

UroToday – Our study of nephron sparing surgery in renal cell carcinoma (RCC) invading the segmental branches of the renal vein is consistent with the trend towards increased utilization of “partial nephrectomy” during surgical management of RCC. This strategy is particularly useful in those with preexisting impairment of renal function and with a modest follow-up we have found good cancer control in these select patients…

Go to Source… Continue reading

Single Institutional Experience With Nephron-Sparing Surgery For Pathologic Stage T3bNxM0 Renal Cell Carcinoma Confined To The Renal Vein

March 19, 2010

UroToday – Our study of nephron sparing surgery in renal cell carcinoma (RCC) invading the segmental branches of the renal vein is consistent with the trend towards increased utilization of “partial nephrectomy” during surgical management of RCC. This strategy is particularly useful in those with preexisting impairment of renal function and with a modest follow-up we have found good cancer control in these select patients…

Go to Source… Continue reading

Statement From American Heart Association CEO Nancy Brown On Congressional Approval Of The PACT Act

March 19, 2010

We’re pleased that Congress has taken another significant step in reducing tobacco use in the U.S. with passage of the Prevent All Cigarette Trafficking (PACT) Act of 2009. This measure will support ongoing efforts to protect children and adults from heart disease, stroke and other chronic illnesses linked to tobacco use. The bill regulates Internet and mail-order sales of tobacco products, restricting children’s access to tobacco products online and ensuring that all appropriate taxes are paid when tobacco products are sold. This legislation will have a tremendous impact on public health…

Go to Source… Continue reading

Statement From American Heart Association CEO Nancy Brown On Congressional Approval Of The PACT Act

March 19, 2010

We’re pleased that Congress has taken another significant step in reducing tobacco use in the U.S. with passage of the Prevent All Cigarette Trafficking (PACT) Act of 2009. This measure will support ongoing efforts to protect children and adults from heart disease, stroke and other chronic illnesses linked to tobacco use. The bill regulates Internet and mail-order sales of tobacco products, restricting children’s access to tobacco products online and ensuring that all appropriate taxes are paid when tobacco products are sold. This legislation will have a tremendous impact on public health…

Go to Source… Continue reading

Statement From American Heart Association CEO Nancy Brown On Congressional Approval Of The PACT Act

March 19, 2010

We’re pleased that Congress has taken another significant step in reducing tobacco use in the U.S. with passage of the Prevent All Cigarette Trafficking (PACT) Act of 2009. This measure will support ongoing efforts to protect children and adults from heart disease, stroke and other chronic illnesses linked to tobacco use. The bill regulates Internet and mail-order sales of tobacco products, restricting children’s access to tobacco products online and ensuring that all appropriate taxes are paid when tobacco products are sold. This legislation will have a tremendous impact on public health…

Go to Source… Continue reading

First Patient Treated In Phase II Trial Of Anticancer Hsp90 Inhibitor

March 19, 2010

The Institute of Cancer Research (ICR) is to receive a milestone payment triggered by the first patient receiving a drug it helped develop in a Phase II clinical trial. The drug, an Hsp90 inhibitor known as AUY-922, is being tested in a range of cancers. It works by targeting and inactivating a crucial molecule called Hsp90, which cancer cells are dependant on for growth. Hsp90 is a molecular chaperone – a helper molecule that is essential for the cancer-causing properties of the products of many cancer genes…

Go to Source… Continue reading

First Patient Treated In Phase II Trial Of Anticancer Hsp90 Inhibitor

March 19, 2010

The Institute of Cancer Research (ICR) is to receive a milestone payment triggered by the first patient receiving a drug it helped develop in a Phase II clinical trial. The drug, an Hsp90 inhibitor known as AUY-922, is being tested in a range of cancers. It works by targeting and inactivating a crucial molecule called Hsp90, which cancer cells are dependant on for growth. Hsp90 is a molecular chaperone – a helper molecule that is essential for the cancer-causing properties of the products of many cancer genes…

Go to Source… Continue reading

Recent Comments:

  • symptoms of dementia: What's the difference between dementia and Alzheimers? what is the difference? I think my father may be suffering one of these? does anyone know the w...
  • rani: good blog thank 4 the info...
  • JourneyHome: McCarran-Ferguson was originally designed to empower both the federal government and the individual states so that they could act to prevent insurance...
  • Hydro Closet: Hi, I thought I would say you have a wonderful site and rich content. I bookmarked your site and have it in my reader now...looking forward to future ...
  • Allan Ono: Getting more usage from drugs already approved by the FDA for new indications seems like a very good way to expand treatment options without the hyper...